Feed KTTA
KT
Pasithea Therapeutics Corp.
KTTA · NASDAQ
$0.48 -1.72% (-$0.01)
1M +1.54%
Market Cap $16.1M
P/E Ratio -
Div. Yield -
ROE 85.85%
Bulios Fair Price
$0.44
8.4% downside
Preț actual
$0.48
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile KTTA sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
100 /100
Cheap P/B 0.29x
P/E N/A
EV/EBITDA N/A
Growth
76 /100
Growing Book val. growth 9.12%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 37.74%
ROE 85.85%
ROA 33.91%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 11.35x
Int. coverage N/A
Stability
24 /100
Unstable Beta 0.29x
EPS volatility 53.16%
Profitable years 0
Întreabă StockBot despre KTTA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tiago Reis Marques
Employees
5
Headquarters
Miami Beach
Evenimente viitoare
12 NOV.
Earnings
Upcoming earnings report